The Journal of Clinical Endocrinology & Metabolism · 2013 · 90 citations · 16 references
MedicineEndocrinologyInternal MedicineHemostasisPediatric HematologyPulmonologyAdrenal DisordersAdrenal EndocrinologyAdrenal HormonesAntiphospholipid SyndromeThrombosisAcute Adrenal InsufficiencyAdrenal Insufficiency SyndromesPrimary Adrenal InsufficiencyPrimary Antiphospholipid SyndromeSecondary Adrenal InsufficiencySecondary Antiphospholipid SyndromeThrombosis In Antiphospholipid Syndrome
CONTEXT: Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction is a rare and life-threatening manifestation of the antiphospholipid syndrome (APLS). Data on the long-term outcome are scarce. OBJECTIVE: The aims of the present study were to analyze the long-term outcome related to APLS per se and to characterize the course of adrenal involvement. DESIGN: We conducted a retrospective study of patients with bilateral adrenal hemorrhage-adrenal infarction secondary to APLS seen in the Department of Internal Medicine of Pitié-Salpêtrière Hospital in Paris (France) between January 1990 and July 2010. RESULTS: Three patients died during the acute phase related to APLS manifestations. Sixteen patients (7 males; 9 females) were followed up during a median period of 3.5 years (range 0.3-28.1 years). Three episodes of recurrent thrombosis were noted. One patient died from cerebral hemorrhage 3 months after the onset of adrenal insufficiency. Repeated Synacthen tests showed complete absence of response in 8 of the 10 patients assessed; cortisol and aldosterone increased appropriately in one patient and to some extent in another one. Dehydroepiandrosterone levels and 24-hour urinary epinephrine levels remained abnormally low in all evaluated patients. Adrenal imaging performed more than 1 year after the initial event revealed completely atrophic glands in 9 of 11 patients. CONCLUSIONS: This particular subset of APLS patients who survive the acute phase has a rather favorable long-term outcome. Although adrenal dysfunction is generally irreversible, adrenocortical function may, at least partially, recover in rare cases. In this view, measurement of early morning cortisol during follow-up is indicated to detect these patients.
16
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
Munther A. Khamashta, María José Cuadrado, F Mujić et al. · New England Journal of Medicine · 1995 · 1.5K citations · Full text
Update of the guidelines for lupus anticoagulant detection
Vittorio Pengo, Armando Tripodi, Guido Reber et al. · Journal of Thrombosis and Haemostasis · 2009 · 1.2K citations · Full text
Ricard Cervera, Rosa Serrano, Guillermo Pons‐Estel et al. · Annals of the Rheumatic Diseases · 2014 · 962 citations · Full text